4-(2,3-Epoxypropoxy)carbazole
CAS: 51997-51-4
Ref. 3D-FE22767
| 1kg | 466.00 € | ||
| 2kg | 715.00 € | ||
| 100g | 90.00 € | ||
| 250g | 167.00 € | ||
| 500g | 272.00 € |
Estimated delivery in United States, on Friday 5 Jul 2024
Product Information
Name:
4-(2,3-Epoxypropoxy)carbazole
Synonyms:
- 4-Oxiranylmethoxy-9H-carbazole4-(Oxiranylmethoxy)-9H-carbazole
- 4-(2,3-Epoxy Propoxy) Carbazole
- 4-(2,3-Epoxy Proxy) Carbazole
- 4-(2,3-Epoxyporpaneoxy)Carbazo
- 4-(2,3-Epoxyporpanoxy)-Carbazole
- 4-(2,3-Epoxypropaneoxy)Carbazole
- 4-(2,3-Epoxypropanoxy)Carbazole
- 4-(2,3-Epoxypropoxy)-9h-Carbazole
- 4-(2-Oxiranylmethoxy)-9h-Carbazole
- 4-(Glycidyloxy)carbazole
- See more synonyms
- 4-(oxiran-2-ylmethoxy)-9H-carbazole
- 4-Epoxypropanoxycarbazole
- 4-Glycidyloxycarbazole
- 4-Oxiranylmethoxy-9h-Carbazole
- 9H-Carbazole, 4-(2-oxiranylmethoxy)-
- 9H-Carbazole, 4-(oxiranylmethoxy)-
- Carvedilol Intermediates
CAS:
Description:
4-(2,3-Epoxypropoxy)carbazole is a molecule that is synthesized from the reactants epichlorohydrin and propylene oxide. This drug binds to the benzodiazepine receptor and has shown potential for treating Alzheimer's disease, cancer, and other ailments. The enantiomer of this molecule has been shown to have anti-tumor effects in mice with breast cancer. 4-(2,3-Epoxypropoxy)carbazole also binds to the benzodiazepine receptor in the brain and blocks neurotransmitter release.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
239.27 g/mol
Formula:
C15H13NO2
Purity:
Min. 95%
Color/Form:
White Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: 3D-FE22767 4-(2,3-Epoxypropoxy)carbazole
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
